Chronic Stress May Be Aging the Brain Before Alzheimer’s Appears
A large study suggests that cumulative cortisol exposure and the loss of a healthy daily rhythm may help identify cognitive decline earlier
Older adults with the highest cumulative cortisol exposure experienced faster cognitive decline, while those with moderate cortisol variation across the day declined more slowly. The findings suggest that the body’s ability to regulate stress may matter as much as the amount of stress it carries.
Medicine usually searches for cognitive decline inside the brain. This study points to a process happening across the entire body.
Cortisol is not merely a “stress hormone.” It is part of a daily regulatory system that helps us wake, respond to demands, mobilize energy, and recover. The concern is not that cortisol rises. The concern is that exposure remains high or the normal rhythm loses its flexibility.
That makes this more interesting than the familiar claim that stress is bad for the brain. It suggests that cognitive aging may be influenced by how effectively the body absorbs stress and returns to baseline potentially years before Alzheimer’s disease becomes clinically visible.
Study Details
Researchers followed 3,895 community-dwelling older adults enrolled in the Chicago Health and Aging Project. Their average age was nearly 77, almost two-thirds were women, and more than 64% were Black.
Participants provided saliva samples when they awakened, in the afternoon, and at bedtime. They also underwent repeated cognitive assessments during follow-up of up to 11 years.
The study was presented at the Alzheimer’s Association International Conference
Methodology
Instead of treating cortisol as a single number, researchers calculated five measures covering three dimensions of cortisol regulation:
Intraday variability: How much cortisol changed across the day.
Cumulative exposure: The average level and total cortisol output.
Diurnal change: How cortisol moved from morning toward bedtime.
The analysis adjusted for age, sex, race, education, body mass index, medical conditions, medication use, smoking, alcohol consumption, and APOE ε4 status.
This approach matters because two people can have similar average cortisol levels while displaying very different daily rhythms. One may show a strong rise-and-fall pattern. The other may remain relatively flat, suggesting a less responsive stress-regulation system.
Key Findings
Participants in the highest quintile of cumulative cortisol exposure had poorer cognitive performance at baseline and experienced faster cognitive decline over time.
Moderate intraday cortisol variability was associated with slower decline. This is an important distinction: the study does not suggest that cortisol should remain uniformly low. A healthy system is supposed to fluctuate.
Black participants showed lower cumulative cortisol exposure but flatter daily rhythms and less intraday variability than white participants. However, the relationship between cortisol patterns and cognitive decline was broadly similar across both groups.
No cortisol measure was significantly associated with the development of Alzheimer’s disease. That analysis included only 825 participants and 92 new Alzheimer’s cases, making it much smaller than the cognitive-decline analysis.
What the Findings Really Mean
The most useful conclusion is not that “stress causes dementia.”
The stronger interpretation is that cumulative cortisol exposure may capture physiological wear that appears before a clinical diagnosis. Salivary cortisol could eventually become one component of a broader early-warning system combining cognition, vascular health, metabolism, inflammation, amyloid, tau, and other measures.
The findings may also help explain why chronic stress is not adequately described by how stressed someone says they feel. Perceived stress and physiological stress overlap, but they are not identical. A person can feel functional while the body is carrying a persistent regulatory burden.
Important Limitations
This was an observational study, so it cannot prove that elevated cortisol caused cognitive decline. Early cognitive changes, disrupted sleep, illness, medications, or altered daily routines could themselves affect cortisol.
Cortisol was measured three times during a single day. That is practical for a large population study, but it may not represent an individual’s usual pattern across weeks or months. The study also did not measure perceived stress.
The reported changes in cognition were modest, and there was no demonstrated association with incident Alzheimer’s disease. These findings are therefore better understood as a biomarker signal requiring replication not as a clinical test.
Implications for Practice
Salivary cortisol is inexpensive, non-invasive, and easier to collect repeatedly than blood or cerebrospinal fluid. Those qualities make it attractive for large-scale research and, eventually, longitudinal screening.
It is not ready for routine dementia-risk testing. Researchers must first show that multi-day cortisol profiles are reliable, add useful information beyond existing risk factors, and lead to interventions that improve outcomes.
Patients should not interpret this study as a reason to purchase consumer cortisol tests or “cortisol-lowering” supplements. Cortisol is essential. The potential target is healthier regulation and recovery, not indiscriminate suppression.
Bottom Line
The aging brain may be shaped not only by what accumulates inside it, but also by what the rest of the body is forced to carry.
High cumulative cortisol exposure was associated with faster cognitive decline, while a more flexible daily pattern appeared protective. Salivary cortisol is not an Alzheimer’s test, but it may become a useful window into cognitive aging before disease becomes obvious.